BMY vs CW · P/E 17, rev $24.46B vs P/E 43, rev $1.84B
Bristol-Myers Squibb Company (BMY) versus Curtiss-Wright Corporation (CW) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Curtiss-Wright Corporation (CW) is a aerospace & defense company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CW revenue for 2026-06-30 was $1.84B. Net income was $279.4M. CW currently screens at market cap $18.20B and trailing P/E 42.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CW currently screens at market cap $18.20B and trailing P/E 42.9.
Not investment advice. Open the BMY and CW stock pages for the full models.
Not investment advice.